355 related articles for article (PubMed ID: 26254540)
21. Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition.
Roh JL; Kim EH; Jang H; Shin D
Free Radic Biol Med; 2017 Mar; 104():1-9. PubMed ID: 28057599
[TBL] [Abstract][Full Text] [Related]
22. Non-invasive Use of Positron Emission Tomography to Monitor Diethyl maleate and Radiation-Induced Changes in System x
Čolović M; Yang H; Merkens H; Colpo N; Bénard F; Schaffer P
Mol Imaging Biol; 2019 Dec; 21(6):1107-1116. PubMed ID: 30838549
[TBL] [Abstract][Full Text] [Related]
23. Combination Therapy with Sulfasalazine and Valproic Acid Promotes Human Glioblastoma Cell Death Through Imbalance of the Intracellular Oxidative Response.
Garcia CG; Kahn SA; Geraldo LHM; Romano I; Domith I; Silva DCLE; Dos Santos Assunção F; Ferreira MJ; Portugal CC; de Souza JM; Romão LF; Netto ADP; Lima FRS; Cossenza M
Mol Neurobiol; 2018 Aug; 55(8):6816-6833. PubMed ID: 29349577
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial dysfunction enhances cisplatin resistance in human gastric cancer cells via the ROS-activated GCN2-eIF2α-ATF4-xCT pathway.
Wang SF; Chen MS; Chou YC; Ueng YF; Yin PH; Yeh TS; Lee HC
Oncotarget; 2016 Nov; 7(45):74132-74151. PubMed ID: 27708226
[TBL] [Abstract][Full Text] [Related]
25. Cystine/Glutamate Antiporter (xCT) Is Required for Chief Cell Plasticity After Gastric Injury.
Meyer AR; Engevik AC; Willet SG; Williams JA; Zou Y; Massion PP; Mills JC; Choi E; Goldenring JR
Cell Mol Gastroenterol Hepatol; 2019; 8(3):379-405. PubMed ID: 31071489
[TBL] [Abstract][Full Text] [Related]
26. Redox Regulation of Stem-like Cells Though the CD44v-xCT Axis in Colorectal Cancer: Mechanisms and Therapeutic Implications.
Ju HQ; Lu YX; Chen DL; Tian T; Mo HY; Wei XL; Liao JW; Wang F; Zeng ZL; Pelicano H; Aguilar M; Jia WH; Xu RH
Theranostics; 2016; 6(8):1160-75. PubMed ID: 27279909
[TBL] [Abstract][Full Text] [Related]
27. Sulfasalazine attenuates ACL transection and medial menisectomy-induced cartilage destruction by inhibition of cystine/glutamate antiporter.
Tsai WY; Tsai RY; Liu CC; Wu JL; Wong CS
J Orthop Res; 2016 Apr; 34(4):650-7. PubMed ID: 26466556
[TBL] [Abstract][Full Text] [Related]
28. EAAT and Xc⁻ Exchanger Inhibition Depletes Glutathione in the Transformed Human Lens Epithelial Cell Line SRA 01/04.
Langford MP; Redens TB; Liang C; Kavanaugh AS; Texada DE
Curr Eye Res; 2016; 41(3):357-66. PubMed ID: 25897760
[TBL] [Abstract][Full Text] [Related]
29. Ambidextrous Approach To Disrupt Redox Balance in Tumor Cells with Increased ROS Production and Decreased GSH Synthesis for Cancer Therapy.
Kou L; Sun R; Xiao S; Zheng Y; Chen Z; Cai A; Zheng H; Yao Q; Ganapathy V; Chen R
ACS Appl Mater Interfaces; 2019 Jul; 11(30):26722-26730. PubMed ID: 31276364
[TBL] [Abstract][Full Text] [Related]
30. 2a, a novel curcumin analog, sensitizes cisplatin-resistant A549 cells to cisplatin by inhibiting thioredoxin reductase concomitant oxidative stress damage.
Zhou B; Huang J; Zuo Y; Li B; Guo Q; Cui B; Shao W; Du J; Bu X
Eur J Pharmacol; 2013 May; 707(1-3):130-9. PubMed ID: 23524096
[TBL] [Abstract][Full Text] [Related]
31. ROS Mediate xCT-Dependent Cell Death in Human Breast Cancer Cells under Glucose Deprivation.
Chen MC; Hsu LL; Wang SF; Hsu CY; Lee HC; Tseng LM
Cells; 2020 Jul; 9(7):. PubMed ID: 32630312
[TBL] [Abstract][Full Text] [Related]
32. The proteasome inhibitor lactacystin enhances GSH synthesis capacity by increased expression of antioxidant components in an Nrf2-independent, but p38 MAPK-dependent manner in rat colorectal carcinoma cells.
Huseby NE; Ravuri C; Moens U
Free Radic Res; 2016; 50(1):1-13. PubMed ID: 26530909
[TBL] [Abstract][Full Text] [Related]
33. Novel analogs of sulfasalazine as system x
Patel D; Kharkar PS; Gandhi NS; Kaur E; Dutt S; Nandave M
Drug Dev Res; 2019 Sep; 80(6):758-777. PubMed ID: 31199023
[TBL] [Abstract][Full Text] [Related]
34. Metformin enhances the sensitivity of colorectal cancer cells to cisplatin through ROS-mediated PI3K/Akt signaling pathway.
Zhang P; Zhao S; Lu X; Shi Z; Liu H; Zhu B
Gene; 2020 Jun; 745():144623. PubMed ID: 32222530
[TBL] [Abstract][Full Text] [Related]
35. IGF-I regulates redox status in breast cancer cells by activating the amino acid transport molecule xC-.
Yang Y; Yee D
Cancer Res; 2014 Apr; 74(8):2295-305. PubMed ID: 24686172
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
[TBL] [Abstract][Full Text] [Related]
37. A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose.
Joly JH; Delfarah A; Phung PS; Parrish S; Graham NA
J Biol Chem; 2020 Jan; 295(5):1350-1365. PubMed ID: 31914417
[TBL] [Abstract][Full Text] [Related]
38. Sulfasalazine induces haem oxygenase-1 via ROS-dependent Nrf2 signalling, leading to control of neointimal hyperplasia.
Kim JY; Cho HJ; Sir JJ; Kim BK; Hur J; Youn SW; Yang HM; Jun SI; Park KW; Hwang SJ; Kwon YW; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
Cardiovasc Res; 2009 Jun; 82(3):550-60. PubMed ID: 19234301
[TBL] [Abstract][Full Text] [Related]
39. Suppression of the xCT-CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin.
Wang F; Yang Y
Breast Cancer Res Treat; 2014 Aug; 147(1):203-10. PubMed ID: 25085754
[TBL] [Abstract][Full Text] [Related]
40. Reactive oxygen species-mediated synergistic and preferential induction of cell death and reduction of clonogenic resistance in breast cancer cells by combined cisplatin and FK228.
Pluchino LA; Choudhary S; Wang HC
Cancer Lett; 2016 Oct; 381(1):124-32. PubMed ID: 27477899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]